本次吸收合并有利于进一步提高公司运营效率、优化资源配置、降低管理成本，符合公司发展战略，有 利于公司持续、稳定、健康发展。本次涉及吸收合并的合并方与被合并方，其财务报表均已纳入公司合 并财务报表范围，吸收合并后不会对公司合并报表产生实质性影响，不会对公司整体业务发展和持续盈 利能力产生不利影响，亦不存在损害公司及股东特别是中小股东利益的情形。 截至目前，四川济生堂兴尚生物科技有限责任公司、北京弘健已注销完成，四川康弘中药材种植有限公 司吸收合并成都康弘医药贸易有限公司正在履行相关法定程序。 格隆汇10月10日丨康弘药业(002773.SZ)公布，近日，北京弘健已收到北京经济技术开发区市场监督管 理局出具的《登记通知书》及《注销核准通知书》，北京弘健提交的注销登记申请材料齐全，符合法定 形式，对北京弘健注销事项予以登记，并经该局核定，准予注销。因此，北京康弘生物吸收合并北京弘 健相关工商手续已办理完成。吸收合并后，北京康弘生物存续经营，其公司名称、股权结构、经营范 围、注册资本均保持不变。 ...

国盛金控吸收合并国盛证券又有新进展！ 9月4日，国盛金控（002670.SZ）公告称，陆箴侃因工作调整原因申请辞去公司总经理职务，辞职后仍 担任公司和子公司董事及董事会专门委员会委员职务。 公司董事长刘朝东将代行总经理职责，直至董事会聘任新任总经理。 今年年初，国盛证券原总裁徐丽峰因年龄原因辞任，目前总裁职务由副总裁唐文峰代为履行职责。如 今，加之国盛金控总经理辞职，"新国盛证券"总经理虚位以待。 此前8月27日，国盛证券官网发布公示公告称，经资格审查、测试、组织考察、体检等环节，赵景亮拟 作为国盛证券股份有限公司总经理聘任人选。 据21世纪经济报道记者了解，赵景亮为财达证券（600906.SH）副总经理，分管自营业务条线。截至9 月5日上午，仍登记注册在财达证券。 国盛金控总经理辞职 9月4日，国盛金控公告称，公司董事会于近日收到总经理陆箴侃的书面辞职报告。因工作调整原因，陆 箴侃申请辞去公司总经理职务，辞职后仍担任公司和子公司董事及董事会专门委员会委员职务。根据有 关规定，陆箴侃的辞职报告自送达董事会之日起生效。 国盛金控表示，因聘任新任总经理尚需履行相应的工作程序，为保证公司经营工作的正常开展，公司董 ...

Core Viewpoint - The resignation of Lu Zhenkan as the General Manager of Guosheng Financial Holdings marks a significant leadership change as the company prepares for its transformation into Guosheng Securities, with a focus on enhancing its financial services capabilities and operational efficiency [2][3][7]. Group 1: Leadership Changes - Lu Zhenkan has submitted his resignation as General Manager due to work adjustments but will continue to serve as a director and committee member [3]. - Liu Chaodong, the Chairman, will temporarily assume the role of General Manager until a new appointment is made [2][3]. - Zhao Jingliang, previously the Deputy General Manager of Caida Securities, has been selected as the new General Manager for the upcoming Guosheng Securities [4][5]. Group 2: Company Transformation - Guosheng Financial Holdings is undergoing a merger with its wholly-owned subsidiary, Guosheng Securities, which will result in a name change to Guosheng Securities [4][7]. - The merger aims to consolidate resources, improve efficiency, and focus on the core securities business, ultimately enhancing service capabilities for the real economy [7]. - The company has received approval from the China Securities Regulatory Commission (CSRC) for the merger, with plans for business license updates and employee transitions following the merger completion [7]. Group 3: Financial Performance - In the first half of the year, Guosheng Financial Holdings reported total revenue of 1.136 billion yuan, a year-on-year increase of 32.10% [8]. - The net profit attributable to shareholders reached 209 million yuan, up 369.91% compared to the same period last year, driven by increased securities brokerage income and reduced credit impairment losses [8].

Group 1 - The company is holding the first bondholders' meeting for "Hua Chen Convertible Bonds" in 2025 to respect the rights of all bondholders and ensure the smooth conduct of the meeting [1][4] - The meeting will allow bondholders to express their opinions, ask questions, and vote on various proposals, with specific rules for speaking and voting outlined [2][3][8] - The company will absorb its wholly-owned subsidiary, Xuzhou Qinen Electric Equipment Co., Ltd., to optimize resource allocation and reduce management costs, with the merger approved by the board of directors [5][9] Group 2 - Xuzhou Qinen Electric Equipment Co., Ltd. has a registered capital of 5 million yuan and reported revenues of 707.88 million yuan and a net profit of 68.19 million yuan for the first half of 2025 [6] - The merger will not change the company's registered capital, name, or management structure, and the financial results of the subsidiary are already included in the company's consolidated financial statements [7][9] - The purpose of the merger is to enhance operational efficiency and will not adversely affect the company's normal operations or the interests of shareholders, particularly minority shareholders [9]

Meeting Details - The second meeting of the fifth board of directors of Tianjin Lianlong New Materials Co., Ltd. was held on August 17, 2025, via telephone and email notifications [1] - All 7 directors attended the meeting, which was chaired by Chairman Li Haiping, and the meeting procedures complied with relevant laws and regulations [1] Financial Reporting - The board confirmed that the 2025 semi-annual report and its summary were prepared and reviewed in accordance with legal requirements, accurately reflecting the company's operational status for the first half of 2025 [2] - The voting results for the approval of the semi-annual report were unanimous, with 7 votes in favor and no opposition [2] Corporate Restructuring - The board approved the absorption merger of Tianjin Aoruifu Biopharmaceutical Co., Ltd. with Tianjin Aolifu Biotechnology Co., Ltd., which aims to optimize the company's equity structure and improve management efficiency [2][3] - The investment in Aoruifu will increase from 4 million yuan to 6.5 million yuan, raising the ownership stake to 50.71%, maintaining Aoruifu as a subsidiary [3] Financing Strategy - The board agreed to apply for the registration and issuance of medium-term notes totaling up to 2 billion yuan to enhance financing channels and optimize the financing structure [3][4] - The issuance plan requires approval from the shareholders' meeting and registration with the trading association, with the board authorized to handle related matters [4] Upcoming Shareholder Meeting - A third temporary shareholders' meeting is scheduled for September 15, 2025, to be conducted with both on-site and online voting [4]

Core Viewpoint - Heshun Petroleum (603353) has announced plans to utilize up to 200 million RMB of idle self-owned funds for securities investment and to absorb its wholly-owned subsidiary, Xiangtan Zhongyou Sales Co., Ltd. [1][2][3] Company Announcements - Heshun Petroleum's board approved the use of idle self-owned funds for securities investment, with a limit of 200 million RMB, valid for 12 months and can be rolled over [1][2] - The company has established a Securities Investment Management System to regulate investment activities, ensuring compliance with national laws and safeguarding the interests of the company and its shareholders [2] - The board also approved the absorption of its wholly-owned subsidiary, Xiangtan Zhongyou Sales Co., Ltd., which will be legally dissolved post-merger, with all its business, assets, personnel, debts, and credits inherited by Heshun Petroleum [1][2]

Core Viewpoint - Chengdu Kanghong Pharmaceutical Group Co., Ltd. has approved the absorption merger of its wholly-owned subsidiary Sichuan Jishengtang Pharmaceutical Co., Ltd. with its wholly-owned subsidiary Sichuan Jishengtang Xingshang Biotechnology Co., Ltd., which will enhance operational efficiency and optimize resource allocation [1][2]. Group 1 - The board of directors approved the merger on April 25, 2025, and the merger will not change the name, shareholding structure, or registered capital of Jishengtang [1][2]. - The merger aims to improve operational efficiency, reduce management costs, and align with the company's development strategy for sustainable growth [2]. - The financial statements of both the merging and merged entities are already included in the company's consolidated financial statements, ensuring no substantial impact on overall business development or profitability [2].

Group 1 - The company plans to merge its wholly-owned subsidiaries, Hunan Zejia Equity Investment Co., Ltd. and Hunan Taijia Intelligent Technology Co., Ltd., to optimize its operational management structure and improve overall operational efficiency [1][2] - The merger was approved during the sixth board meeting and the second extraordinary shareholders' meeting held on July 14 and July 31, 2025, respectively [1][2] - Following the merger, the legal entity status of Hunan Zejia and Taijia Intelligent will be canceled, and all assets, debts, personnel, and business will be inherited by the company [1] Group 2 - Creditors are notified that they have 30 days from receiving the notice, or 45 days from the announcement date if not notified, to claim their debts or request guarantees [2][3] - Creditors must submit written requests along with relevant proof documents to the company to exercise their rights [2][3] - The announcement includes details on the required materials for debt claims and the submission process [3]

Meeting Details - The third extraordinary general meeting of shareholders was held on July 25, 2025, at 15:00 [1] - Voting was conducted both on-site and online, with specific times for voting through the Shenzhen Stock Exchange [1] Attendance - A total of 3 domestic shareholders attended, holding 748,526,688 shares, which is 63.71% of the total voting shares [1] - 137 B-share shareholders attended, holding 29,511,307 shares, which is 2.51% of the total voting shares [1] Voting Results - The meeting approved the merger of the wholly-owned subsidiary Zhejiang Qilun Complete Technology Development Co., Ltd. with 99.90% of the total votes in favor [1] - Domestic shareholders voted 100% in favor, while B-share shareholders voted 97.46% in favor [1] Legal Opinion - The legal counsel confirmed that the meeting's procedures, attendance qualifications, and voting methods complied with relevant laws and regulations, making the voting results valid [1]

Overview of the Merger - The company plans to absorb its wholly-owned subsidiary, Zhejiang Turbine Complete Technology Development Co., Ltd. (referred to as "Complete Company"), to enhance resource allocation efficiency and optimize overall operational effectiveness [1][4] - The merger will not constitute a major asset restructuring or related party transaction [1][3] Financial Impact - The merger will not materially affect the company's financial status as the financial statements of the Complete Company are already included in the company's consolidated financial statements [4] - There will be no changes to the company's total share capital or registered capital as a result of the merger [5] Operational Changes - Following the merger, all assets, personnel, debts, rights, and obligations of the Complete Company will be transferred to the company, which will continue its operations while the Complete Company will be deregistered [3][4] - The merger is expected to improve the company's management structure and operational efficiency, aligning with its development strategy [4]